Companies: 10,795·Total market cap: $144.5T
Immutep Limited

Immutep Limited

IMMPNASDAQHealthcare● Active
$0.37
$-0.01(-2.04%)
Market Cap$54365531
P/E Ratio—
52W High$3.53
52W Low$0.29
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Immutep Limited (IMMP) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001506184 · IMMP · NASDAQ · as of Jun 8, 2026

Filing snapshot

727
Total Filings
6-K
Latest Form
2026-06-05
Most Recent
2012
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001506184 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2025-10-24
Fiscal Year End
Oct 24, 2025
Accession No.
0001193125-25-249346
Primary Document
d33851d20f.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001506184 · Accession 0001193125-25-249346

Latest Key Filings

6-KQuarterly Report
6-K
2026-06-05
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
6-K
2026-06-05
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-01
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-01
View
3Initial Statement of Beneficial Ownership
3
2026-04-16
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-04-16
View
3Initial Statement of Beneficial Ownership
3
2026-04-13
View
3Initial Statement of Beneficial Ownership
3
2026-04-13
View
3Initial Statement of Beneficial Ownership
3
2026-04-07
View
3Initial Statement of Beneficial Ownership
3
2026-04-01
View
3Initial Statement of Beneficial Ownership
3
2026-04-01
View
3Initial Statement of Beneficial Ownership
3
2026-04-01
View
3Initial Statement of Beneficial Ownership
3
2026-04-01
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-03-20
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-03-16
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-02-26
View
Showing 1–15 of 727 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001506184  |  Exchange: NASDAQ · Healthcare

Immutep Limited (NASDAQ: IMMP) has submitted 727 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2012. As a Healthcare sector company with CIK 0001506184, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Immutep Limited's most comprehensive regulatory disclosure. The most recent Immutep Limited 10-K was filed on 2025-10-24 for fiscal year ending 2025. Historical IMMP 10-K annual reports are available from 2012 through 2025.

Investors researching Immutep Limited SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
CAPR SEC Filings →ACHV SEC Filings →CABA SEC Filings →CADL SEC Filings →ALLO SEC Filings →VNDA SEC Filings →EDIT SEC Filings →TRDA SEC Filings →
→ IMMP Financials→ IMMP Earnings→ IMMP Insider Trades

Frequently Asked Questions

IMMP SEC Filings · 8 questions

Immutep Limited (IMMP) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 727 filings and access original documents at no cost. Immutep Limited's CIK is 0001506184.

IMMP SEC filingsImmutep Limited SEC documentsfind IMMP 10-K